Neuropharmacology of S-adenosyl methionine.
D000818:Animals; D000928:Antidepressive Agents; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D003704:Dementia / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D005492:Folic Acid / Q000032:analysis / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D001523:Mental Disorders / Q000188:drug therapy*; D008716:Methionine Adenosyltransferase / Q000378:metabolism; D008745:Methylation; D009422:Nervous System Diseases / Q000188:drug therapy*; D010743:Phospholipids / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012436:S-Adenosylmethionine / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D013569:Synapses / Q000378:metabolism; D009435:Synaptic Transmission
D000928:Antidepressive Agents; D001679:Biogenic Amines; D010743:Phospholipids; D011506:Proteins; D006897:Hydroxyindoleacetic Acid; D012436:S-Adenosylmethionine; D005492:Folic Acid; D008716:Methionine Adenosyltransferase